Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Langer Robert
Relationship:  
City:   Newton
State:   MA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   23,234,698    

Indirect Shares

  68,091      
Direct Value   $64,517,299    

Indirect Value

  $0      
Total Shares   23,302,789      
Total Value   $64,517,299      


Momenta Pharmaceuticals Inc
 $49,857,155 Echo Therapeutics Inc
 $121 Invivo Therapeutics Holdings Corporation
 $2,750,442 DNIB Upwind Inc
 $0 Cartesian Therapeutics, Inc
 $9,673,727 Kala Pharmaceuticals, Inc.
 $2,235,854 Moderna, Inc.
 $0 Korro Bio
 $0 Lyra Therapeutics, Inc.
 $0 Sqz Biotechnologies Co
 $0 Seer, Inc.
 $0 Momenta Pharmaceuticals Inc
 $49,857,155 Echo Therapeutics Inc
 $121 Invivo Therapeutics Holdings Corporation
 $2,750,442 DNIB Upwind Inc
 $0 Cartesian Therapeutics, Inc
 $9,673,727 Kala Pharmaceuticals, Inc.
 $2,235,854 Moderna, Inc.
 $0 Korro Bio
 $0 Lyra Therapeutics, Inc.
 $0 Sqz Biotechnologies Co
 $0 Seer, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2008-08-08 950,022 0    Premium*  
            Echo Therapeutics Inc ECTE Director 2009-12-11 603,450 2004-05-26 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV 10% Owner 2013-06-05 7,433,628 0    Premium*  
            DNIB Upwind Inc BIND Director 2016-08-26 738,424 0    Premium*  
            Cartesian Therapeutics, Inc RNAC 10% Owner 2016-06-21 457,603 0    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-19 326,402 0    Premium*  
            Moderna, Inc. MRNA Director 2022-04-28 11,467,664 2022-04-28 42,396    Premium*  
            Rubius Therapeutics, Inc. RUBY Director 2019-10-14 0 2019-01-14 0    Premium*  
            Korro Bio KRRO Director 2020-11-17 214,326 2020-11-17 25,695    Premium*  
            Lyra Therapeutics, Inc. LYRA Director 2020-05-05 15,167 0    Premium*  
            Sqz Biotechnologies Co SQZ 10% Owner 2020-10-29 243,987 0    Premium*  
            Seer, Inc. SEER 2024-06-12 784,025 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
MNTA Momenta Pharmaceuticals I... Director   –       •      –    2008-08-08 4 S $16.81 $336,200 D/D (20,000) 950,022 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-04-13 4 S $2.39 $95,982 D/D (40,160) 8,056,953 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-04-16 4 S $2.40 $383,616 D/D (159,840) 7,897,113 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-06-26 4 S $2.42 $306,251 D/D (126,550) 7,770,563 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-06-27 4 S $2.40 $32,280 D/D (13,450) 7,757,113 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-06-28 4 S $2.30 $34,560 D/D (15,000) 7,742,113 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-06-29 4 S $2.31 $57,167 D/D (24,780) 7,717,333 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2012-07-02 4 S $2.39 $48,265 D/D (20,220) 7,697,113 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-01-15 4 S $2.47 $87,587 D/D (35,436) 7,661,677 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-01-16 4 S $2.46 $253,523 D/D (102,874) 7,558,803 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-01-17 4 S $2.46 $129,076 D/D (52,425) 7,506,378 0 -
BIND DNIB Upwind Inc Director   –       •      –    2016-08-26 4 OE $0.44 $6,600 D/D 15,000 738,424 0 -
RUBY Rubius Therapeutics, Inc. Director   –       •      –    2019-01-14 4 OE $0.15 $1,125 D/D 7,500 7,500 0 -
RUBY Rubius Therapeutics, Inc. Director   –       •      –    2019-04-15 4 OE $0.15 $1,125 D/D 7,500 7,500 0 -
RUBY Rubius Therapeutics, Inc. Director   –       •      –    2019-07-15 4 OE $0.15 $1,125 D/D 7,500 7,500 0 -
RUBY Rubius Therapeutics, Inc. Director   –       •      –    2019-10-14 4 OE $0.15 $1,125 D/D 7,500 7,500 0 -
MRNA Moderna, Inc. Director   •       •      –    2022-04-28 4 OE $0.00 $0 D/D 703 11,467,664 0 -
MNTA Momenta Pharmaceuticals I... Director   –       •      –    2004-06-21 3 IO $0.00 $0 D/D 0 939,264 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2010-10-26 3 IO $0.00 $0 D/D 0 8,262,360 -
BIND DNIB Upwind Inc Director   –       •      –    2013-09-19 3 IO $0.00 $0 D/D 0 723,424 -
RNAC Cartesian Therapeutics, I... 10% Owner   –       –       •   2016-06-21 3 IO $0.00 $0 D/D 0 457,603 -
KALA Kala Pharmaceuticals, Inc... Director   –       •       •   2017-07-19 3 IO $0.00 $0 D/D 0 326,402 -
KRRO Korro Bio Director   –       •      –    2019-10-02 3 IO $0.00 $0 I/I 0 25,695 -
KRRO Korro Bio Director   –       •      –    2019-10-02 3 IO $0.00 $0 D/D 0 271,238 -
LYRA Lyra Therapeutics, Inc. Director   –       •      –    2020-04-30 3 IO $0.00 $0 D/D 0 14,499 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed